Mucosal vaccines: novel advances in technology and delivery.
about
Enhancing oral vaccine potency by targeting intestinal M cellsTowards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownPlant-made oral vaccines against human infectious diseases-Are we there yet?The mucosal immune system: From dentistry to vaccine developmentCochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisationVaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A VirusSublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncEImmune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa).Cellobiose-coated poly(lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization.Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.Mucosal Lactobacillus vectored vaccines.First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensTransgenic plant-based oral vaccines.Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.Viral tricks to grid-lock the type I interferon system.Bioadhesive delivery systems for mucosal vaccine delivery.Optimizing efficacy of mucosal vaccines.Nanogel-based antigen-delivery system for nasal vaccines.Challenges in mucosal vaccines for the control of infectious diseases.Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.Current state and challenges in developing oral vaccines.Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.Development of a nanogel-based nasal vaccine as a novel antigen delivery system.PilVax - a novel peptide delivery platform for the development of mucosal vaccines.Probiotic Lactobacillus casei expressing porcine antimicrobial peptide PR39 elevates antibacterial activity in the gastrointestinal tract.Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain.Do microRNAs play a role in the activity of plant-based vaccines?Prospects on the Use of sp. to Develop Oral Vaccines
P2860
Q21089613-5BCCAB94-A2E7-4160-BF96-91CD80D20AEBQ21296712-CB204704-0FF7-4AE4-B69C-3B34AF47D2BCQ26783111-EB2DAE88-64C1-4AD8-9081-A1236B589663Q26783887-59F66CFA-FAF8-4A89-B121-18DA027AD7D7Q27316184-EA50ECEB-4BE8-4AD0-8F69-1B593027E519Q30401849-00D25F36-1907-486A-8A35-C8CBE5829852Q30427778-D6A69788-7B66-40C2-B155-06822C188589Q33725145-EDB181F8-6FFB-464B-AB17-6903BE4EE25AQ33811867-D7ECA091-34E5-4F53-8CF0-74795E606E77Q34607470-84894770-036F-41FC-8604-6DA158701CD4Q35112676-42CE12E4-D6CF-47DE-B97D-D8D9A371B54DQ35236588-3742EE5A-B6F9-4ADE-ABAD-BA387E27ADDEQ35539544-E42FF4F9-83E6-4F1C-8164-D9332C08C7DCQ35886523-31CD1D9D-379F-4846-A733-13DD558F2A4EQ36605149-31CC6076-181E-467E-A381-AA403FE68FA5Q37521871-10E6C33A-3841-4FFD-BFB7-6218553D2E1CQ37578465-D5370E9D-AD4D-421F-92BE-9AAB13314295Q37744913-2EADCE35-8C59-4F5F-B312-C3737133EEC5Q37748492-A76CC980-473A-48BF-A909-3CBA47805798Q37764230-BA7DD6A9-172C-4037-9A9D-9F8F43D34D18Q37805519-BD8E4BA3-B923-4F2C-9F1E-3AB22129ED6EQ38059754-9B556D8A-067D-4911-8E65-B31805CA5256Q38191009-1BD5A706-659D-4F12-8080-A6B1B91A3399Q38219010-E196243B-F8EB-4DDB-B233-805731D8B8D9Q38335733-D94C3E4E-1780-4A93-8308-8BADB6A025EEQ38941665-44BFB47C-FB72-4D94-8967-0359F8FDD94FQ39079605-F823117A-2858-4206-AC02-5CD568E257F7Q39259629-94EDCCD9-14C7-44FB-8FBF-02438B122167Q41382022-7ECD882F-4C23-4F17-AD51-F995512943DDQ43838346-2593AADC-0357-44BF-8BEF-388DCC4C417CQ48009563-FC3AC2C1-59F2-4D82-B152-BA66BC94D1E0Q48507555-C191B2DA-B366-4572-866F-D8B57CE759BEQ49961146-FE22D434-817C-4FCB-B72D-6DAB54AB9672Q51059732-BA3855A4-ED15-473F-8F36-2B3C56BDF768Q51602972-DC02CC39-2D88-42AC-9E43-E048A4618B2FQ52715734-D352A7CD-D7CB-47F0-84CA-6B4EF54FD9CCQ53329382-FAFEA3BA-A65F-4C42-BDD3-E89E3810A739Q58556430-BBDFC8B3-2D36-475C-A364-E0BF30BFF369
P2860
Mucosal vaccines: novel advances in technology and delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal vaccines: novel advances in technology and delivery.
@en
Mucosal vaccines: novel advances in technology and delivery.
@nl
type
label
Mucosal vaccines: novel advances in technology and delivery.
@en
Mucosal vaccines: novel advances in technology and delivery.
@nl
prefLabel
Mucosal vaccines: novel advances in technology and delivery.
@en
Mucosal vaccines: novel advances in technology and delivery.
@nl
P2860
P356
P1476
Mucosal vaccines: novel advances in technology and delivery.
@en
P2093
Hiroshi Kiyono
Yoshikazu Yuki
P2860
P304
P356
10.1586/ERV.09.61
P577
2009-08-01T00:00:00Z